search for


The Journal of Pharmaceutical Society of Korea

1. Aims and Scope

Yakhak Hoeji is an official domestic journal of the Pharmaceutical Society of Korea and has been published since 1948. Yakhak Hoeji is a peer-reviewed journal devoted to all areas of pharmaceutical sciences including basic, translational, clinical, and pharmacy-related social studies. This journal aims to represent the academic output on pharmaceutical sciences and pharmacy practice to build an academic exchange platform among pharmaceutical scientists, researchers, and pharmacists so that the readers could update the recent scientific knowledge and academic trends, ultimately leading to further development on the pharmaceutical sciences.
Manuscripts will be considered for publication on the condition that the results reported are based on research works that has not been published elsewhere in any journal.

2. Eligibility

Author (at least one author in case of multiple authors) of submitted manuscript must be a member (honoured, permanent, general or student member). Non-members can submit their manuscript upon the approval of the editorial board.

3. Copyright

  • The copyright of published manuscript is held by the Pharmaceutical Society of Korea.

4. Manuscript language

  • Yakhak Hoeji (The Journal of Pharmaceutical Society of Korea) must be written in Korean or English language.
    Manuscripts should be prepared as follows:
    Abstract: English language
    Text: Korean or English
    Figure, Table: English
    References: English

5. Manuscript types and format

The Pharmaceutical Society of Korea publishes original research articles, short reports, continued reports and review articles.
Authors shoud not submit a manuscript that has been previously published or being reviewed simultaenously elsewhere at home or abroad.
Original research articles and short reports should include an Abstract in English.

5.1. Original research articles

Original research articles must contain substantial novel findings obtained from a creative study.

  • (1) Manuscript length
    There is no limit on the length of a manuscript, but the content of manuscript must be clear to understand and avoid wordiness.
  • (2) Manuscript format
    Manuscripts should include the following sections in the order listed: Introduction, experimental methods, experiment results and discussion, conclusion, acknowledgement, references. The order can be changed to the Theory section (introduction, discussion and conclusion), Experiment section (experimental methods and experiment results), acknowledgements and references. Heading is not used for the Introduction and Theory sections

5.2. Short reports

Short reports must contain novel findings or valuable data.

  • (1) Manuscript length
    The length of short reports should not exceed three pages when printed. There can be an exception upon the approval of the editorial board. However, the manuscript should not exceed 2,600 words, including figures and tables.
  • (2) Manuscript format
    The standard format required for original research articles is recommended, but combining multiple sections into one section is allowed.

5.3. Continued reports

Continued reports must contain novel experimental results in need of urgent disclosure. Any reason for the need for urgent publication should be stated separately in text.

  • (1) Manuscript length
    The length of short reports should not exceed two pages when printed. There can be an exception upon the approval of the editorial board.
  • (2) Manuscript format
    The standard formatting is not required for clinical experiments.

5.4. Review articles

Review articles should contain the review of studies results and measurement data published at home or abroad. Review articles are usually written upon reqeust of the editorial board.

6. Manuscript format

Review articles must be written in a format set by the Pharmaceutical Society of Korea. But there can be an exception, depending on research field such as social pharmacy.

7. Manuscript submission

Manuscripts can be submitted via online manuscript submission section on our website ( If your manuscript that is too large for submission on the website, email a copy of your manuscript to or send an electronic copy on CD to our office (194, Hyoryeong- ro, Seocho-gu, Seoul 06708, Korea).
All manuscripts must be typed on A4 paper using MSWord or Hangul. A manuscript should contain title, abstract, text, references, tables and figures and explanatory captions. The entire manuscript should be double spaced with margins of 3.5 cm on both sides and 1.5 cm at the top and bottom.

8. Review process

  • (1) Your manuscript will be stamped with date of the day it is received via one of channels specified on Artlcle 6 (1) above.
  • (2) And the editorial board acknowledges receipt of manuscript by sending email to you.
  • (3) Once manuscript is peer reviewed by two reviewers, the editorial board will classify review results into the following four categories:
    • a. Accepted for publication
    • b. Open to acceptance after the suggested revision
    • c. Resubmit after the suggested revisions
    • d. Not accepted for publication
  • (4) The editorial board returns any manuscript that is rejected or requires further modification to the respective author with explanation.
  • (5) If the revised version of manuscript is not received within 2 months after notice, we assume the manuscript has been withdrawn.
  • (6) The editorial board can modify manuscript structure or style, if necessary, upon consent of author.

9. Manuscript edition

  • (1) Authors are fully responsible for editions of their manuscripts.
  • (2) Authors can edit their manuscript that is peer-reviewed, if they want.
  • (3) But they should not revise content or add new content on their own. If peer-reviewed manuscript is re-edited for changes or new content, it is subject to re-review of the editorial board. And its author is responsible for paying any expenses incurred by the re-review. If the submission of revised manuscript is delayed beyond deadline, authors can postpone the publication.

10. Correction

  • (1) Authors are required to submit their corrections to us within 1 month after publication, if they need to make any corrections to their articles that have been published.
  • (2) Their corrections will be published in the next edition of the journal.

11. Charges to authors (Submission fee, publication fee and printing costs)

  • (1) Authors are required to pay KRW 50,000 for submission fee and KRW 20,000 per page of their manuscript published.
  • (2) Authors will receive a pdf file of their article. Authors who want to receive reprints (30 copies) should pay KRW 50,000.
  • 12. Research and publication ethics

    For the policies on the research and publication ethics not stated in this instructions, International standards for editors and authors ( editors-and-authors) can be applied.
    Process for Managing Research and Publication Misconduct : When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author's idea or data, complaints against editors, and soon, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics. org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.

    Additional clauses

    • 1. These manuscript submission guidelines took effect March 1, 2017.
    • 2. These manuscript submission guidelines are revised by the editorial board at February 15, 2017.

    December 2019, 63 (6)